Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of PfizerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record. See the Pfizer group view.
As of Nov 13, 2026, FDA's public records list Lederle Laboratories with 96 drug applications and 3 510(k) clearances. The most recent is a 510(k) clearance dated Jun 8, 1977: ANTI-CONVULSANT DRUG CONTROL.
| Date | Record | Source |
|---|---|---|
| Jun 8, 1977 | ANTI-CONVULSANT DRUG CONTROLK770975 · DIC | 510(k) clearances |
| Apr 5, 1977 | MICRO/PETTOR, SMIK770307 · JQW | 510(k) clearances |
| Oct 29, 1976 | ROTATOR, FIXED SPEEDK760467 · JQC | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
